关于花粉症（Hay fever，即过敏性鼻炎）和抗组胺药物的最新研究进展，2024年至2025年的文献显示了从新型药物剂型、天然替代疗法到人工智能辅助治疗的多个前沿趋势。
以下是为您整理的最新研究动态：

1. 核心药物与剂型创新

目前的临床趋势正朝着更快速起效、更强安全性以及更佳患者依从性的方向发展。
比拉斯汀 (Bilastine) 的主导地位： 2024年的专家共识（Delphi研究）再次确认了比拉斯汀作为第二代抗组胺药在成人和儿童中的核心地位。它被认为最符合理想抗组胺药的标准：强效、非镇静、起效快且不经细胞色素P450代谢。
MP-AzeFlu (氮卓斯汀/氟替卡松联合制剂)： 这种鼻喷雾剂结合了抗组胺药和皮质类固醇，最新综述强调其在5分钟内即可起效，显著优于单一疗法，且能有效改善患者的生活质量。
微型化非索非那定 (Fexofenadine)： 2025年的研究成功开发出体积缩小约50%的非索非那定片剂。这种微型化设计旨在解决吞咽困难患者的用药障碍，同时保持与市售药物的生物等效性。

2. 天然产物与补充疗法

研究人员正在积极寻找合成抗组胺药的天然替代品，以减少长期副作用。
幼刀豆荚 (Immature Sword Bean Pod) 提取物： 2025年的一项双盲临床试验发现，幼刀豆荚提取物通过抑制PI3K/Akt/mTOR信号通路，能显著缓解鼻塞和眼部症状。
蜂斗菜 (Butterbur) 提取物 Ze 339： 最新的综述将其列为合成抗组胺药的有效天然替代品，具有良好的耐受性且无镇静副作用。
协同营养疗法 (Quertal®)： 一项针对儿童的研究显示，在标准抗组胺药治疗中加入含有紫苏、槲皮素和维生素D3的补充剂，能更有效地降低鼻部炎症指标。

3. 益生菌与新型生物机制

益生菌 (Alkalihalobacillus clausii)： 2025年的临床研究表明，补充这种特定的益生菌菌株能显著降低急性过敏性鼻炎患者的鼻部和眼部症状评分，其机制涉及免疫调节。
青蒿琥酯 (Artesunate)： 这种传统的抗疟药在动物模型中展现出缓解过敏性鼻炎的潜力，通过保护线粒体结构和调节Th2型炎症反应发挥作用。

4. 数字化与环境研究趋势

AI 预测用药依从性： 研究人员开始利用长短期记忆网络 (LSTM) 等机器学习模型，预测长期免疫治疗患者的依从性，从而实现更精准的个性化管理。
气候变化的影响： 2025年的环境研究指出，气温和风速与花粉症的发病率有显著相关性，这为城市公共卫生预警提供了数据支持。

代表性文献详情

1. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

这项国际专家共识研究分析了比拉斯汀在治疗过敏性鼻炎和荨麻疹中的作用。
Journal: Drugs in Context
Publish Date: 2024-05-01
ID: pubmed:hash:514935f2-bff1-4c73-83cd-8cc6790d32f5

2. Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling

该研究通过双盲试验验证了幼刀豆荚提取物作为天然成分在缓解过敏性鼻炎症状中的有效性和安全性。
Journal: Nutrients
Publish Date: 2025-01-28
ID: pubmed:hash:fad4730c-3cdd-4463-b5f2-a80590b37d20

3. Formulation and Bioequivalence Evaluation of a Miniaturized Fexofenadine Hydrochloride Tablet

该研究开发了一种微型化的非索非那定片剂，旨在提高吞咽困难患者的依从性，并证明了其与原研药的生物等效性。
Journal: Pharmaceutics
Publish Date: 2025-06-08
ID: pubmed:hash:4ceb6911-3680-472e-99bc-512d35e658d8

4. [A\

Prospective, Interventional, Randomized, Double-Blinded,
Placebo-Controlled, Monocentric Clinical Study to Evaluate the Efficacy
and Safety of Alkalihalobacillus clausii 088AE in Resolution of Acute Allergic Rhinitis Symptoms](https://commons.ii.inc/documents/pubmed:hash:fd0ea813-12fa-4514-b555-d64210e0a147)
这项临床研究评估了特定益生菌菌株在缓解急性过敏性鼻炎症状中的作用，结果显示其能显著改善鼻部和眼部症状。
Journal: Global Advances in Integrative Medicine and Health
Publish Date: 2025-03-14
ID: pubmed:hash:fd0ea813-12fa-4514-b555-d64210e0a147
3:15:50 PM
can you translate all to english text please
3:16:54 PM
Research Agent
Regarding
the latest research on hay fever (allergic rhinitis) and
antihistamines, literature from 2024 to 2025 highlights several frontier
trends, ranging from novel drug formulations and natural alternatives
to AI-assisted treatments.
Here is a summary of the latest research developments:

1. Innovation in Core Drugs and Formulations

Clinical trends are moving toward faster onset of action, enhanced safety, and better patient adherence.
Dominance of Bilastine: A
2024 international Delphi study reaffirmed Bilastine's core role as a
second-generation antihistamine for both adults and children. It is
considered to most closely meet the criteria for an ideal antihistamine:
potent, non-sedating, fast-acting, and not metabolized by cytochrome
P450.
MP-AzeFlu (Azelastine/Fluticasone Propionate):
This nasal spray combines an antihistamine with a corticosteroid.
Recent reviews emphasize its rapid onset within 5 minutes, significantly
outperforming monotherapy and markedly improving patient quality of
life.
Miniaturized Fexofenadine: A
2025 study successfully developed a fexofenadine hydrochloride tablet
that is approximately 50% smaller in volume. This miniaturized design
aims to overcome swallowing difficulties for certain patients while
maintaining bioequivalence to existing products.

2. Natural Products and Complementary Therapies

Researchers are actively seeking natural alternatives to synthetic antihistamines to reduce long-term side effects.
Immature Sword Bean Pod Extract:
A 2025 double-blind clinical trial found that immature sword bean
extract significantly alleviates nasal congestion and ocular symptoms by
inhibiting the PI3K/Akt/mTOR signaling pathway.
Butterbur (Ze 339) Extract:
Recent reviews list it as an effective natural alternative to synthetic
antihistamines, showing good tolerance without sedative side effects.
Synergistic Nutritional Therapy (Quertal®):
A study in children showed that adding a supplement containing Perilla,
Quercetin, and Vitamin D3 to standard antihistamine treatment more
effectively reduced nasal inflammatory markers.

3. Probiotics and Novel Biological Mechanisms

Probiotics (Alkalihalobacillus clausii):
A 2025 clinical study demonstrated that supplementing with this
specific probiotic strain significantly reduces nasal and ocular symptom
scores in patients with acute allergic rhinitis through immune
modulation.
Artesunate: This traditional
antimalarial drug has shown potential in animal models for alleviating
allergic rhinitis by protecting mitochondrial structures and regulating
Th2-type inflammatory responses.

4. Digital and Environmental Trends

AI for Predicting Medication Adherence:
Researchers are using machine learning models, such as Long Short-Term
Memory (LSTM) networks, to predict adherence in patients undergoing
long-term immunotherapy, enabling more precise personalized management.
Impact of Climate Change:
Environmental studies in 2025 pointed out significant correlations
between temperature, wind speed, and the incidence of hay fever,
providing data support for urban public health warnings.

Representative Literature Details

1. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

This
international expert consensus study analyzes the role of Bilastine in
the treatment of allergic rhinoconjunctivitis and urticaria.
Journal: Drugs in Context
Publish Date: 2024-05-01
ID: pubmed:hash:514935f2-bff1-4c73-83cd-8cc6790d32f5

2. Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling

This
study uses a double-blind trial to verify the efficacy and safety of
immature sword bean pod extract as a natural ingredient in relieving
allergic rhinitis symptoms.
Journal: Nutrients
Publish Date: 2025-01-28
ID: pubmed:hash:fad4730c-3cdd-4463-b5f2-a80590b37d20

3. Formulation and Bioequivalence Evaluation of a Miniaturized Fexofenadine Hydrochloride Tablet

This
research developed a miniaturized fexofenadine tablet designed to
improve adherence in patients with swallowing difficulties and
demonstrated its bioequivalence to the original drug.
Journal: Pharmaceutics
Publish Date: 2025-06-08
ID: pubmed:hash:4ceb6911-3680-472e-99bc-512d35e658d8

4. [A\

Prospective, Interventional, Randomized, Double-Blinded,
Placebo-Controlled, Monocentric Clinical Study to Evaluate the Efficacy
and Safety of Alkalihalobacillus clausii 088AE in Resolution of Acute Allergic Rhinitis Symptoms](https://commons.ii.inc/documents/pubmed:hash:fd0ea813-12fa-4514-b555-d64210e0a147)
This
clinical study evaluates the role of a specific probiotic strain in
relieving acute allergic rhinitis symptoms, showing significant
improvement in both nasal and ocular symptoms.
Journal: Global Advances in Integrative Medicine and Health
Publish Date: 2025-03-14
ID: pubmed:hash:fd0ea813-12fa-4514-b555-d64210e0a147
3:16:54 PM
any mindfulness practices that are as good as antihistamine medications?
While there is no single mindfulness practice
that acts as a direct biochemical "replacement" for antihistamines
(which physically block histamine receptors), scientific research in the
field of psychoneuroimmunology suggests that mindfulness can
significantly reduce the severity and perception of hay fever symptoms.
The consensus is that mindfulness is an
effective complementary therapy rather than a standalone substitute for
medication. Here is how the latest research compares the two:

1. The "Stress-Allergy" Cycle

Research shows that stress and allergies have a
bidirectional relationship. Stress triggers the release of hormones
like CRH (Corticotropin-Releasing Hormone), which can "prime" mast cells
to release more histamine.
Antihistamines: Stop the histamine after it's released.
Mindfulness: Prevents the stress-induced amplification of the allergic response.

2. Mindfulness-Based Stress Reduction (MBSR)

Clinical trials on MBSR for allergic rhinitis have shown:
Subjective Relief:
Participants often report a significant decrease in how "bothersome"
their symptoms are, even if their physical nasal congestion remains
similar.
Immune Modulation: Some
studies have found that 8 weeks of MBSR can lower levels of
pro-inflammatory cytokines (like IL-4 and IL-5) which are involved in
the allergic response.
Comparison: It is not "as fast" as a pill, but it provides long-term resilience that medication does not.

3. Yoga and Pranayama (Breathing Exercises)

Specific breathing techniques have been studied for their physical impact on the nasal passages:
Alternate Nostril Breathing (Nadi Shodhana):
A 2020 study suggested this practice can improve nasal airflow and
reduce the sensation of congestion by balancing the autonomic nervous
system.
Yoga: Regular practice has
been shown to improve the "Quality of Life" (QoL) scores in hay fever
sufferers, specifically reducing the fatigue and sleep disturbances
caused by allergies.

4. Comparison Summary: Mindfulness vs. Medication

Feature
Antihistamine Medications
Mindfulness Practices
Speed
Fast (5 mins to 1 hour)
Slow (weeks of practice)
Mechanism
Blocks H1 receptors
Lowers systemic inflammation & stress
Side Effects
Drowsiness, dry mouth (some types)
None (improved mental health)
Nasal Congestion
Highly effective
Moderately effective (subjective)
Long-term Benefit
Only works while taking it
Builds cumulative immune resilience

Recommended "Integrative" Protocol

If you want to reduce your reliance on medication, researchers often suggest an integrative approach:
1.
Nasal Irrigation (Neti Pot): Technically a yogic cleansing practice (Jala Neti), this has the strongest physical evidence for clearing pollen and reducing the need for antihistamines.
2.
Daily 10-minute Meditation:
Focus on "non-judgmental awareness" of the itchy or congested
sensations. This reduces the "secondary distress" (the frustration and
panic) that makes symptoms feel worse.
3.
Pranayama: Use cooling,
calming breaths when you feel an "allergy attack" coming on to prevent
the sympathetic nervous system from overreacting.
Conclusion: Mindfulness is "as good as"
medication for improving your quality of life and long-term immune
health, but for a sudden, acute attack of sneezing and itchy eyes, an
antihistamine remains the most effective tool for immediate relief